Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in Candida glabrata
Open accessPublished version of a preprint
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Candida glabrata is a prominent opportunistic fungal pathogen of humans. The increasing incidence of C. glabrata infections is attributed to both innate and acquired resistance to antifungals. Previous studies suggest the transcription factor Pdr1 and several target genes encoding ABC transporters are critical elements of pleiotropic defense against azoles and other antifungals. This study utilizes Hermes transposon insertion profiling to investigate Pdr1-independent and Pdr1-dependent mechanisms that alter susceptibility to the frontline antifungal fluconazole. Several new genes were found to alter fluconazole susceptibility independent of Pdr1 ( CYB5 , SSK1 , SSK2 , HOG1 , TRP1 ). A bZIP transcription repressor of mitochondrial function ( CIN5 ) positively regulated Pdr1 while hundreds of genes encoding mitochondrial proteins were confirmed as negative regulators of Pdr1. The antibiotic oligomycin activated Pdr1 and antagonized fluconazole efficacy likely by interfering with mitochondrial processes in C. glabrata . Unexpectedly, disruption of many 60S ribosomal proteins also activated Pdr1, thus mimicking the effects of the mRNA translation inhibitors. Cycloheximide failed to fully activate Pdr1 in a cycloheximide-resistant Rpl28-Q38E mutant. Similarly, fluconazole failed to fully activate Pdr1 in a strain expressing a low-affinity variant of Erg11. Fluconazole activated Pdr1 with very slow kinetics that correlated with the delayed onset of cellular stress. These findings are inconsistent with the idea that Pdr1 directly senses xenobiotics and support an alternative hypothesis where Pdr1 senses cellular stresses that arise only after engagement of xenobiotics with their targets. IMPORTANCE: Candida glabrata is an opportunistic pathogenic yeast that causes discomfort and death. Its incidence has been increasing because of natural defenses to our common antifungal medications. This study explores the entire genome for impacts on resistance to fluconazole. We find several new and unexpected genes can impact susceptibility to fluconazole. Several antibiotics can also alter the efficacy of fluconazole. Most importantly, we find that Pdr1—a key determinant of fluconazole resistance—is not regulated directly through binding of fluconazole and instead is regulated indirectly by sensing the cellular stresses caused by fluconazole blockage of sterol biosynthesis. This new understanding of drug resistance mechanisms could improve the outcomes of current antifungals and accelerate the development of novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 1×
“Reads were demultiplexed using CutAdapt (70) and mapped to the BG2 reference genome (30) using Bowtie2 (71).”
MethodCutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390 · cited 1×
“Bedfiles were generated and visualized using the IGV genome browser (72).”
MethodPappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636 · cited 1×
“to azole-class antifungals, easily acquired resistance to other antifungals, and nosocomial spread (3, 4).”
BackgroundESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Cornely, O. A., Arikan-Akdagli, S., Dannaoui, E., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 863
Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680 · cited 1×
“glabrata rose from 12% to 29% between 1999 and 2012 (1) and to 38% in 2020, even surpassing C.”
BackgroundAzole antifungal agents: Emphasis on new triazoles
Saag, M. S., & Dismukes, W. E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.1.1 · Cited by 474 · cited 1×
“The frontline antifungal fluconazole, as well as other azoles, targets lanosterol 14-alpha-demethylase (Erg11/Cyp51), a cytochrome P450 enzyme in the endoplasmic reticulum of fungal cells that is necessary for biosynthesis of ergosterol (5).”
BackgroundCoste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · cited 1×
“albicans lacks Pdr1 and instead utilizes a distantly related transcription factor Tac1 to drive expression of CDR1 and other efflux pumps (56).”
BackgroundHansen, J. L., Moore, P. B., & Steitz, T. A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00668-5 · Cited by 393 · cited 1×
“glabrata exhibited eightfold increase in resistance to cycloheximide and no change in resistance to anisomycin, a distinct translation inhibitor that binds elsewhere on translating ribosomes (43) (Fig.”
BackgroundDom34 Rescues Ribosomes in 3′ Untranslated Regions
Guydosh, N. R., & Green, R. (2014) · Cell · doi:10.1016/j.cell.2014.02.006 · Cited by 363
A nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343
Self-citationFerrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“glabrata also exhibited hyper-vir ulence in mouse models of invasive candidiasis even in the absence of antifungals (9, 20, 21).”
BackgroundVermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285 · cited 1×
“This finding is consistent with previous studies (8, 10), showing that Pdr1 can induce expression of PDH1 and SNQ2, which independently confer weak resistance to fluconazole in cdr1∆ strains (11, 31).”
ResultSanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247 · cited 1×
“glabrata, causing strong fluconazole resistance (9, 13, 22, 24).”
BackgroundTsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · cited 3×
“7) as expected because CDR1 is not expressed in pdr1∆ strains (9, 10).”
BackgroundVermitsky, J., Earhart, K. D., Smith, W. L., Homayouni, R., Edlind, T. D., & Rogers, P. D. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05235.x · Cited by 233 · cited 10×
“Translation dysfunction increases fluconazole resistance via Pdr1 and Cdr1 Transposon disruption of 131 non-mitochondrial genes also increased resistance to fluconazole (z > 3.0) in BG14 but not in pdr1∆ or cdr1∆ strains.”
BackgroundResultInfluentialShingu-Vazquez, M., & Traven, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05184-11 · Cited by 209 · cited 2×
“Mitochondrial dysfunction caused by either mutations or inhibitors also activated Pdr1, likely through multiple interacting mechanisms (27).”
BackgroundGeber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., & Bennett, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2708 · Cited by 203 · cited 1×
“glabrata were not resistant to fluconazole (63).”
Schwarzmüller, T., Ma, B., Hiller, E., Istel, F., Tscherner, M., Brunke, S., Ames, L., Firon, A., Green, B., Cabral, V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004211 · Cited by 191 · cited 11×
“The ssk1∆::NATr locus with ~500 bp flanking homology was PCR amplified from a CBS138-derived strain (38) and transformed into strains BG14, CGM1094, and CGM1096.”
BackgroundMethodInfluentialSelf-citationVallabhaneni, S., Cleveland, A. A., Farley, M. M., Harrison, L. H., Schaffner, W., Beldavs, Z. G., Derado, G., Pham, C. D., Lockhart, S. R., & Smith, R. M. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv163 · Cited by 187
Cycloheximide resistance in yeast: the gene and its portein
Kaàufer, N. F., Fried, H. M., Schwindinger, W. F., Jasin, M., & Warner, J. R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.10.3123 · Cited by 184
Cormack, B. P., & Falkow, S. (1999) · Genetics · doi:10.1093/genetics/151.3.979 · Cited by 180
Self-citationKaur, R., Castaño, I., & Cormack, B. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1600-1613.2004 · Cited by 167 · cited 3×
“glabrata survival and proliferation in fluconazole (24) and within phagosomes of macrophages (26).”
BackgroundSelf-citationKitada, K., Yamaguchi, E., & Arisawa, M. (1995) · Gene · doi:10.1016/0378-1119(95)00552-h · Cited by 153 · cited 1×
“To generate trp1∆ mutants, the trp1∆::URA3 locus of CBS138-2001T (68) with ~500 bp homology arms was amplified by PCR and transformed into strains BG14, CGM1094, and CGM1096.”
MethodMechanisms of Azole Resistance in Petite Mutants of Candida glabrata
Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., & Bouchara, J.-P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1788-1796.2004 · Cited by 151 · cited 1×
“Alpha-ketoglutarate deficiency may help explain the fluconazole-resistant phenotype of hundreds of other mitochondria-deficient mutants, some of which have arisen naturally in patients with fluconazole-resistant infections (23).”
BackgroundInhibiting fungal multidrug resistance by disrupting an activator–Mediator interaction
Nishikawa, J. L., Boeszoermenyi, A., Vale-Silva, L. A., Torelli, R., Posteraro, B., Sohn, Y.-J., Ji, F., Gelev, V., Sanglard, D., Sanguinetti, M., et al. (2016) · Nature · doi:10.1038/nature16963 · Cited by 146
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144
Torelli, R., Posteraro, B., Ferrari, S., La Sorda, M., Fadda, G., Sanglard, D., & Sanguinetti, M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06143.x · Cited by 141 · cited 1×
“This finding is consistent with previous studies (8, 10), showing that Pdr1 can induce expression of PDH1 and SNQ2, which independently confer weak resistance to fluconazole in cdr1∆ strains (11, 31).”
ResultSilent chromatin determines target preference of the Saccharomyces retrotransposon Ty5
Zou, S., & Voytas, D. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7412 · Cited by 128
Sagatova, A. A., Keniya, M. V., Wilson, R. K., Sabherwal, M., Tyndall, J. D. A., & Monk, B. C. (2016) · Scientific Reports · doi:10.1038/srep26213 · Cited by 117
Azole Binding Properties of Candida albicans Sterol 14-α Demethylase (CaCYP51)
Warrilow, A. G. S., Martel, C. M., Parker, J. E., Melo, N., Lamb, D. C., Nes, W. D., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00587-10 · Cited by 112
Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata
Ferrari, S., Sanguinetti, M., Torelli, R., Posteraro, B., & Sanglard, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017589 · Cited by 110 · cited 1×
“glabrata also exhibited hyper-vir ulence in mouse models of invasive candidiasis even in the absence of antifungals (9, 20, 21).”
BackgroundKsiezopolska, E., Schikora-Tamarit, M. À., Beyer, R., Nunez-Rodriguez, J. C., Schüller, C., & Gabaldón, T. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.084 · Cited by 107 · cited 1×
“erg3mutants arose spontaneously during prolonged passaging in anidulafungin but did not arise during in vitro evolution of fluconazole resistance where gain-of-function missense mutations in PDR1 and ERG11 predominated (64).”
BackgroundIdentification and expression of multidrug resistancerelated ABC transporter genes in Candida krusei
Katiyar, S. K., & Edlind, T. D. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.109.116 · Cited by 104
Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 Regulon
Caudle, K. E., Barker, K. S., Wiederhold, N. P., Xu, L., Homayouni, R., & Rogers, P. D. (2011) · Eukaryotic Cell · doi:10.1128/ec.00073-10 · Cited by 94 · cited 1×
“However, PDH1, SNQ2, and all other targets of Pdr1 (10, 13, 32) individually did not contribute significantly to fluconazole resistance even when disrupted in the cdr1∆ strain, indicating little individual impact of those genes in the conditions employed here.”
BackgroundLamb, D. C., Kelly, D. E., Manning, N. J., Kaderbhai, M. A., & Kelly, S. L. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01548-3 · Cited by 91
Azole Resistance in Candida glabrata
Whaley, S. G., & Rogers, P. D. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0554-5 · Cited by 85 · cited 1×
“glabrata clinical isolates are innately resistant to fluconazole due to two intrinsic regulatory pathways (6).”
BackgroundJain, P., Akula, I., & Edlind, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3195-3201.2003 · Cited by 82
Expression Plasmids for Use in Candida glabrata
Zordan, R. E., Ren, Y., Pan, S.-J., Rotondo, G., Peñas, A. D. L., Iluore, J., & Cormack, B. P. (2013) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.113.006908 · Cited by 82
Self-citationHanlon, S. E., Rizzo, J. M., Tatomer, D. C., Lieb, J. D., & Buck, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019060 · Cited by 81
Nagi, M., Nakayama, H., Tanabe, K., Bard, M., Aoyama, T., Okano, M., Higashi, S., Ueno, K., Chibana, H., Niimi, M., et al. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01470.x · Cited by 68 · cited 1×
“The first pathway involves the transcription factor Upc2A, which drives expression of Erg11 and other enzymes of the ergosterol biosynthesis pathway upon ergosterol depletion (7).”
BackgroundOrta‐Zavalza, E., Guerrero‐Serrano, G., Gutiérrez‐Escobedo, G., Cañas‐Villamar, I., Juárez‐Cepeda, J., Castaño, I., & De Las Peñas, A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12247 · Cited by 61
Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates
Vale-Silva, L., Beaudoing, E., Tran, V. D. T., & Sanglard, D. (2017) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.117.042887 · Cited by 61 · cited 1×
“glabrata, CBS138 [E160-stop (40)] and DSY562 [Y62-stop (41)].”
Whaley, S. G., Zhang, Q., Caudle, K. E., & Rogers, P. D. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01070-18 · Cited by 59 · cited 1×
“This finding is consistent with previous studies (8, 10), showing that Pdr1 can induce expression of PDH1 and SNQ2, which independently confer weak resistance to fluconazole in cdr1∆ strains (11, 31).”
ResultVu, B. G., Thomas, G. H., & Moye-Rowley, W. S. (2019) · mBio · doi:10.1128/mbio.00934-19 · Cited by 59 · cited 2×
“Additionally, hypomorphic mutations in Erg11 (48) and 60S ribosomes (Fig.”
BackgroundVincent, B. M., Langlois, J.-B., Srinivas, R., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., Tidor, B., Buchwald, S. L., & Lindquist, S. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.06.016 · Cited by 58
Gregori, C., Schüller, C., Roetzer, A., Schwarzmüller, T., Ammerer, G., & Kuchler, K. (2007) · Eukaryotic Cell · doi:10.1128/ec.00106-07 · Cited by 57 · cited 2×
“Additionally, three genes that function within the osmo-sensing branch of the HOG pathway (SSK1, SSK2, HOG1) (37) were part of this group.”
BackgroundGale, A. N., Sakhawala, R. M., Levitan, A., Sharan, R., Berman, J., Timp, W., & Cunningham, K. W. (2020) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.120.401595 · Cited by 56
Self-citationQuantitative insertion-site sequencing (QIseq) for high throughput phenotyping of transposon mutantsPreprint
Bronner, I. F., Otto, T. D., Zhang, M., Udenze, K., Wang, C. C. Q., Quail, M. A., Jiang, R. H. Y., Adams, J. H., & Rayner, J. C. (2016) · Genome Research · doi:10.1101/gr.200279.115 · Cited by 50 · cited 1×
“Cells were then pelleted and resuspended in 30 mL of 15% glycerol and 1× SCD medium and frozen at −80°C for long-term storage in 5 mL aliquots before undergoing the QI-seq protocol (67).”
MethodInhibiting mitochondrial phosphate transport as an unexploited antifungal strategy
McLellan, C. A., Vincent, B. M., Solis, N. V., Lancaster, A. K., Sullivan, L. B., Hartland, C. L., Youngsaye, W., Filler, S. G., Whitesell, L., & Lindquist, S. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2534 · Cited by 49 · cited 1×
“albicans deficient in complex III of the respiratory chain increased resistance to fluconazole (58) while a mutant deficient in complex IV decreased resistance to fluconazole (59).”
BackgroundLi, Q., Tsai, H., Mandal, A., Walker, B., Noble, J., Fukuda, Y., & Bennett, J. E. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8716 · Cited by 48
Xu, Z., Green, B., Benoit, N., Schatz, M., Wheelan, S., & Cormack, B. (2020) · Molecular Microbiology · doi:10.1111/mmi.14488 · Cited by 48
Self-citationPaul, S., Bair, T. B., & Moye-Rowley, W. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03921-14 · Cited by 45 · cited 3×
“However, PDH1, SNQ2, and all other targets of Pdr1 (10, 13, 32) individually did not contribute significantly to fluconazole resistance even when disrupted in the cdr1∆ strain, indicating little individual impact of those genes in the conditions employed here.”
BackgroundMalys, N. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh687 · Cited by 41
Vu, B. G., Stamnes, M. A., Li, Y., Rogers, P. D., & Moye-Rowley, W. S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009582 · Cited by 39 · cited 2×
“Upc2A also participates in the second pathway by increasing PDR1 and CDR1 expression (16, 17).”
BackgroundEdlind, T. D., Henry, K. W., Vermitsky, J., Edlind, M. P., Raj, S., & Katiyar, S. K. (2005) · Current Genetics · doi:10.1007/s00294-005-0008-3 · Cited by 38 · cited 1×
“All other mutants were knocked out using the PRODIGE method (69) and the PCR primers listed in Table S3.”
MethodAlenquer, M., Tenreiro, S., & Sá-Correia, I. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00095.x · Cited by 38
Ni, Q., Wang, C., Tian, Y., Dong, D., Jiang, C., Mao, E., & Peng, Y. (2018) · Mycoses · doi:10.1111/myc.12756 · Cited by 37
Siscar-Lewin, S., Gabaldón, T., Aldejohann, A. M., Kurzai, O., Hube, B., & Brunke, S. (2021) · mBio · doi:10.1128/mbio.01128-21 · Cited by 36
Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans
Kaneko, Y., Fukazawa, H., Ohno, H., & Miyazaki, Y. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-013-0639-0 · Cited by 35 · cited 1×
“Secondarily, the artemisinin-related molecules appeared to inhibit Cdr1 activity, and therefore, antagonism of fluconazole efficacy was not observed (53, 54).”
BackgroundVu, B. G., & Moye-Rowley, S. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02098-21 · Cited by 33 · cited 3×
“The membranes were blocked with 10% non-fat milk, probed sequentially with antibodies specific for Erg11 (45) or Pgk1 (Invitrogen, Waltham, MA, USA) and visualized on a Bio-Rad imager using HRP-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA) and Western Blotting Detection Reagents (GE, Ch…”
BackgroundMethodInfluentialKhakhina, S., Simonicova, L., & Moye‐Rowley, W. S. (2018) · Molecular Microbiology · doi:10.1111/mmi.13913 · Cited by 32
Marcet‐Houben, M., Alvarado, M. I., Księżopolska, E., Saus, E., de Groot, P. W. J., & Gabaldón, T. (2022) · BMC Biology · doi:10.1186/s12915-022-01412-1 · Cited by 30 · cited 1×
“glabrata isolates often exhibit enormous genetic diversity that could adaptively alter many traits relevant to virulence, pathogenicity, and drug resistance (65).”
BackgroundCell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata
Xu, Z., Green, B., Benoit, N., Sobel, J. D., Schatz, M. C., Wheelan, S., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 29
Self-citationMeyahnwi, D., Siraw, B. B., & Reingold, A. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07848-8 · Cited by 28
Hossain, S., Veri, A. O., Liu, Z., Iyer, K. R., O’Meara, T. R., Robbins, N., & Cowen, L. E. (2021) · Genetics · doi:10.1093/genetics/iyab095 · Cited by 23
Butts, A., Reitler, P., Nishimoto, A. T., DeJarnette, C. A., Estredge, L. R., Peters, T. L., Veve, M. P., Rogers, P. D., & Palmer, G. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00054-19 · Cited by 18 · cited 1×
“albicans by a Tac1-dependent process (55), suggesting this sensor may detect a different range of stresses than Pdr1 in C.”
BackgroundArtemisinin Targets Transcription Factor PDR1 and Impairs Candida glabrata Mitochondrial Function
Zhu, P., Yue, C., Zeng, X., & Chen, X. (2022) · Antioxidants · doi:10.3390/antiox11101855 · Cited by 17
Cyclic AMP and Fluconazole Resistance in Saccharomyces cerevisiae
Kontoyiannis, D. P., & Rupp, S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1743-1744.2000 · Cited by 16
Zhou, J., Li, J., Cheong, I. H., Liu, N., & Wang, H. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116293 · Cited by 16 · cited 1×
“Secondarily, the artemisinin-related molecules appeared to inhibit Cdr1 activity, and therefore, antagonism of fluconazole efficacy was not observed (53, 54).”
BackgroundDisruption of the Candida albicans CYB5 Gene Results in Increased Azole Sensitivity
Rogers, K. M., Pierson, C. A., Culbertson, N. T., Mo, C., Sturm, A. M., Eckstein, J. A., Barbuch, R. J., Lees, N. D., & Bard, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3425-3435.2004 · Cited by 15
Partial Purification and Characterization of Lathosterol 5-Desaturase from Rat Liver Microsomes1
HONJO, K., Ishibashi, T., & Imai, Y. (1985) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135137 · Cited by 14
Steier, Z., Vermitsky, J.-P., Toner, G., Gygax, S. E., Edlind, T., & Katiyar, S. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02394-12 · Cited by 14 · cited 1×
“glab rata probably by interfering with mitochondrial function (50).”
BackgroundNonidentical function of Upc2A binding sites in the Candida glabrata CDR1 promoter
Vu, B. G., & Moye-Rowley, S. (2022) · Genetics · doi:10.1093/genetics/iyac135 · Cited by 11 · cited 1×
“Upc2A also participates in the second pathway by increasing PDR1 and CDR1 expression (16, 17).”
Background
Cited by
Calcineurin-dependent contributions to fitness in the opportunistic pathogen Candida glabrata
Pavesic, M. W., Gale, A. N., Nickels, T. J., Harrington, A. A., Bussey, M., & Cunningham, K. W. (2024) · mSphere · doi:10.1128/msphere.00554-23 · Cited by 22
Self-citationGenomics insights of candidiasis: mechanisms of pathogenicity and drug resistance
Huang, X., Dong, Q., Zhou, Q., Fang, S., Xu, Y., Hu, L., Chen, J., Li, X. Y., Qin, H., Mu, D., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1531543 · Cited by 24
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 16
Calcineurin is required for Candida glabrata Pdr1 transcriptional activation
Vu, B. G., Šimoničová, L., & Moye-Rowley, S. (2023) · mBio · doi:10.1128/mbio.02416-23 · Cited by 10
Nickels, T. J., Gale, A. N., Harrington, A. A., Timp, W., & Cunningham, K. W. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae173 · Cited by 12
Self-citation
Metadata
- Authors
- Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Cunningham, Kyle W.
- ORCID
- Venue
- mSphere
- Publisher
- American Society for Microbiology
- Published
- 2023-08-24
- Volume
- 8
- Issue
- 4
- Pages
- e0025423-e0025423
- ISSN
- 2379-5042 (ISSN-L)
- PMC
- PMC10449514
- OpenAlex
- W4382010633
- Cited by
- 27
- References
- 75
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 12 · 2023: 1
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSphere (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI153424, R01AI046223)
- HHS | NIH | National Institute of General Medical Sciences (T32-GM007231)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida glabrata, pleiotropic drug resistance, fluconazole resistance, antifungal susceptibility, mitochondrial function, oligomycin, cycloheximide, ERG11, sterol biosynthesis, ABC transporters, opportunistic fungal pathogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.